CI (The Cigna Group): Themes, ETFs, and Basket Ideas
Last updated June 2026
Short answer
What does The Cigna Group do?
The Cigna Group is a large US health-services company built around two main engines. Its Evernorth health-services arm includes Express Scripts, one of the largest pharmacy benefit managers (PBMs) in the country, plus specialty pharmacy, care services, and pharmacy-related businesses; this is now the larger revenue and growth driver. Its Cigna Healthcare arm sells commercial health insurance, primarily to employers and individuals, along with international and supplemental coverage. Cigna makes money by collecting insurance premiums and managing medical costs, and by earning fees and spreads on managing drug benefits, negotiating with manufacturers, and dispensing specialty medications at scale. After exiting most of its Medicare businesses, Cigna is increasingly weighted toward commercial insurance and pharmacy services rather than government programs. It is headquartered in Bloomfield, Connecticut, and serves employers, health plans, government entities, and individuals.
Where is The Cigna Group heading?
1. Evernorth and pharmacy services scale.
Evernorth, anchored by Express Scripts, is Cigna's growth engine. As one of the largest PBMs, it commands enormous negotiating scale with drug manufacturers, and its fast-growing specialty pharmacy business benefits from the rising volume of high-cost specialty and biologic drugs. Expanding services across care delivery, behavioral health, and data give Cigna recurring, fee-based revenue beyond traditional insurance.
2. Stable commercial insurance core.
Cigna Healthcare focuses on employer-sponsored commercial coverage, which is generally more stable and profitable than government programs. By exiting most Medicare businesses, Cigna has reduced exposure to the medical-cost pressures hitting Medicare Advantage peers, sharpening its mix toward steadier commercial and stop-loss insurance.
3. Strong cash generation and capital returns.
The combined business produces substantial free cash flow, which Cigna deploys into a growing dividend and large share buybacks. Disciplined capital allocation and a meaningful repurchase program steadily reduce the share count, supporting per-share earnings growth even when underlying volumes grow modestly.
4. Specialty drug tailwind.
The shift toward expensive specialty and biologic therapies, including GLP-1 weight-loss drugs, increases the value of Cigna's pharmacy management, specialty dispensing, and cost-control capabilities. Evernorth is positioned to manage and profit from this rising drug spend on behalf of employers and health plans.
Risks worth tracking: Cigna faces significant regulatory and political risk: PBMs are under scrutiny from Congress, the FTC, and states over drug-pricing practices and rebate models, and potential reform could pressure the economics of Express Scripts. Health insurers also face rising medical-cost trends and utilization, which can squeeze margins. Concentration in a few large clients (including a major contract with Centene-related and Cigna's own plans) and reliance on retaining big PBM clients add risk. Drug-pricing reform, GLP-1 cost dynamics, litigation, and competitive pressure from vertically integrated rivals like UnitedHealth and CVS all weigh on the outlook. The stock often trades at a low multiple reflecting these regulatory overhangs.
Earnings and valuation (approximate, early 2026)
A simple financial snapshot. These are approximations and refresh quarterly; for current figures see The Cigna Group's investor relations page or your broker.
- Revenue (TTM): ~$250 billion (inflated by pharmacy pass-through revenue)
- Operating margin: thin on a revenue basis (PBM pass-through), measured better on adjusted EPS
- Adjusted EPS: double-digit growth targeted over time
- Dividend yield: ~2%
- P/E (TTM): low, often ~12-15x on forward earnings
- Free cash flow: strong, funding large buybacks
- Segments: Evernorth (pharmacy/health services) and Cigna Healthcare (insurance)
Cigna trades at a low earnings multiple relative to the broad market, a discount that reflects PBM regulatory risk and the optically huge but low-margin pharmacy pass-through revenue. The bull case leans on steady adjusted EPS growth, heavy buybacks, and Evernorth's scale; the discounted valuation is the market pricing in policy and drug-pricing uncertainty.
CI's competitors
Health insurance
Competes with UnitedHealth, Elevance Health (Anthem), Aetna (CVS Health), and Humana in commercial and employer health coverage.
Pharmacy benefit management
Through Express Scripts, competes with CVS Caremark and UnitedHealth's OptumRx, the other two members of the dominant PBM trio, plus smaller and newer transparent PBMs.
Specialty pharmacy and health services
Through Evernorth, competes with CVS Health, Optum, and specialty pharmacy and care-services providers across drug dispensing, behavioral health, and care delivery.
Using CI in a Walnut basket
The most useful question to ask about a single stock is rarely “will it go up?”. It's “does this fit a thesis I actually believe in, and how do I size it alongside other stocks that fit the same thesis?” That's what Walnut is built for.
Open the AI assistant on Walnut and describe a thesis (for example: “the AI infrastructure buildout”, “dividend growth large-caps”, “global semiconductors”) where CI would naturally fit. The AI proposes 5 to 6 constituents with target weights, you review, and you can fund the basket through your broker once you're ready.
Build a basket around CI with Walnut
Use The Cigna Group as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.
FAQ
What is CI's ticker symbol?
+
CI, listed on the New York Stock Exchange. The company is The Cigna Group, headquartered in Bloomfield, Connecticut. It trades during US market hours and is available at every major US brokerage.
What does Cigna do?
+
Cigna is a health-services company. Its Evernorth arm runs Express Scripts, a major pharmacy benefit manager, plus specialty pharmacy and care services, while Cigna Healthcare sells commercial health insurance to employers and individuals. It earns premiums and pharmacy-management fees and spreads.
Who are Cigna's main competitors?
+
In insurance, UnitedHealth, Elevance, CVS/Aetna, and Humana. In pharmacy benefit management, CVS Caremark and UnitedHealth's OptumRx. In specialty pharmacy and health services, CVS and Optum.
What is a PBM and why does it matter for CI?
+
A pharmacy benefit manager negotiates drug prices and rebates and manages prescription benefits for employers and health plans. Cigna's Express Scripts is one of the three largest PBMs. PBMs are Cigna's biggest growth driver but also its biggest regulatory risk.
Why did Cigna exit Medicare?
+
Cigna divested most of its Medicare Advantage and related businesses to focus on commercial insurance and pharmacy services. This reduced its exposure to the rising medical costs and reimbursement pressures that have squeezed Medicare Advantage margins across the industry.
Why is CI's stock cheap on a P/E basis?
+
Cigna trades at a low forward P/E largely because of PBM regulatory and drug-pricing reform risk, plus optically thin margins from pharmacy pass-through revenue. The discount reflects policy uncertainty rather than weak cash generation, which remains strong.
Is CI a Healthcare stock?
+
Yes. Under GICS classification, Cigna is in the Health Care sector, within managed health care and health-care services. It is held across healthcare ETFs and broad market index funds.
Which ETFs hold CI?
+
Broad funds like VOO, VTI, and SPY hold CI. Health-care sector ETFs such as XLV and IHF (health-care providers) hold it at higher weights. Some value and dividend ETFs include it given its low multiple.
Is CI in the S&P 500?
+
Yes. Cigna is a long-standing S&P 500 constituent and is widely held across passive index funds tracking the index.
What is Cigna's market cap?
+
Roughly $80-100 billion as of early 2026, placing it among the large managed-care companies, though smaller than UnitedHealth. The market cap reflects strong cash flow and EPS growth offset by a low valuation multiple tied to PBM regulatory concerns.
Which thematic baskets typically include CI?
+
Cigna commonly appears in healthcare, managed-care, and value baskets. It is also used in dividend or cash-return themes given its buybacks, and in pharmacy or drug-supply-chain baskets through its Express Scripts and Evernorth businesses.
Is CI a good stock to buy?
+
Descriptive, not a recommendation. The bull case is Evernorth's PBM and specialty-pharmacy scale, a steadier commercial-insurance core after exiting Medicare, strong free cash flow, heavy buybacks, and a low valuation. The bear case is significant PBM regulatory and drug-pricing reform risk, rising medical costs, client-concentration risk, and competition from vertically integrated rivals. Whether it fits any portfolio depends on individual goals and risk tolerance. Walnut is informational, not investment advice.
Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with The Cigna Group's investor relations page or your broker before making investment decisions.